Related references
Note: Only part of the references are listed.The Current Status of the Production and Supply of Gallium-68
Krishan Kumar
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution
Gueliz Acker et al.
NEUROSURGICAL FOCUS (2019)
Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications
Riccardo Laudicella et al.
CANCERS (2019)
Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT-planned radiotherapy of high-grade meningiomas
Barbara Zollner et al.
RADIATION ONCOLOGY (2018)
Somatostatin receptor PET/CT (SSTR-PET/CT)
C. Boy et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2018)
Radiosurgery and stereotactic radiotherapy with cyberknife system for meningioma treatment
Rossella Di Franco et al.
NEURORADIOLOGY JOURNAL (2018)
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review
Thomas Graillon et al.
JOURNAL OF NEUROSURGERY (2017)
PET/MRI for Oncologic Brain Imaging: A Comparison of Standard MR-Based Attenuation Corrections with a Model-Based Approach for the Siemens mMR PET/MR System
Ivo Rausch et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
PET imaging in patients with meningioma-report of the RANO/PET Group
Norbert Galldiks et al.
NEURO-ONCOLOGY (2017)
Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients
Dominik Berzaczy et al.
CLINICAL NUCLEAR MEDICINE (2017)
Concordance of 18F-FDG PET Uptake in Tumor and Normal Tissues on PET/MRI and PET/CT
W. Phillip Law et al.
CLINICAL NUCLEAR MEDICINE (2017)
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma
Asim Afaq et al.
CLINICAL NUCLEAR MEDICINE (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
EANO guidelines for the diagnosis and treatment of meningiomas
Roland Goldbrunner et al.
LANCET ONCOLOGY (2016)
68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?
Michael Sommerauer et al.
NEURO-ONCOLOGY (2016)
Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake
Katharina Seystahl et al.
NEURO-ONCOLOGY (2016)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2016)
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
Leland Rogers et al.
JOURNAL OF NEUROSURGERY (2015)
Organs at risk in the brain and their dose-constraints in adults and in children: A radiation oncologist's guide for delineation in everyday practice
Silvia Scoccianti et al.
RADIOTHERAPY AND ONCOLOGY (2015)
CyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerations
Alfredo Conti et al.
SPRINGERPLUS (2015)
Comparison of 68Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results
Ali Afshar-Oromieh et al.
NEURO-ONCOLOGY (2015)
Contribution of 68Ga-DOTATOC PET/CT to Target Volume Delineation of Skull Base Meningiomas Treated With Stereotactic Radiation Therapy
Reinhold Graf et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET/CT and contrast-enhanced MRI
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET
Stefanie Milker-Zabel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
The WHO classification of tumors of the nervous system
P Kleihues et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)